Table 3.
A. In nodal macrometastases* | ||
---|---|---|
Staining intensity | HMW-MAA | MART-1 |
Strong (+++) | 11† (21%) | 1 (2%) |
Intermediate (++) | 28 (54%) | 20 (38%) |
Weak (+) | 13 (25%) | 22 (42%) |
Negative (−) | 0 (0%) | 9 (17%)‡ |
B. Comparison of the percentage of melanoma cells stained in nodal macrometastases§ | ||
Melanoma cells (%) | HMW-MAA | MART-1 |
| ||
100 | 23|| (44%) | 12 (23%) |
99–75 | 17 (33%) | 7 (13%) |
74–50 | 7 (13%) | 9 (17%) |
49–25 | 2 (4%) | 8 (15%) |
24–1 | 3 (6%) | 7 (13%) |
0 (negative) | 0 (0) | 9 (17%)‡ |
>50% | 47 (90%) | 28 (54%) |
C. Comparison of the staining intensity of melanoma cells stained in nodal micrometastases¶ | ||
Staining intensity | HMW-MAA | MART-1 |
| ||
Strong (+++) | 5** | 3 (9%) |
Intermediate (++) | 19 (59%) | 13 (41%) |
Weak (+) | 8 (25%) | 6 (19%) |
Negative (−) | 0 | 10 (31%)‡ |
D. Comparison of the percentage of melanoma cells stained in nodal micrometastases†† | ||
Melanoma Cells (%) | HMW-MAA | MART-1 |
| ||
100 | 9‡‡ (28%) | 3 (9%) |
99–75 | 12 (38%) | 7 (22%) |
74–50 | 8 (25%) | 6 (19%) |
49–25 | 2 (6%) | 4 (13%) |
24–1 | 1 (3%) | 2 (6%) |
0 (negative) | 0 | 10 (31%)§§ |
>50 | 29 (91%) | 16 (50%) |
n = 52 Nodes were analyzed.
Number of nodes with the indicated phenotype.
P < 0.0001.
n = 52 (SLN and non-SLN) were analyzed.
Number of nodes with the indicated phenotype.
n = 32 SLNs were analyzed.
Number of nodes with the indicated phenotype.
n = 32 SLNs were analyzed.
Number of nodes with the indicated phenotype.
P = 0.004.